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The C–C chemokine receptor CCR5 in humans and
rhesus macaques (Macaca mulatta) serves as the
primary coreceptor for cellular entry by macrophage-
tropic strains of human immunodeficiency virus type 1
(HIV-1) and all reported strains of simian
immunodeficiency virus (SIV) [1–6]. Humans
homozygous for a 32 bp deletion allele of CCR5,
resulting in a null phenotype, are highly resistant to
infection by HIV-1 [7–9], prompting development of
therapies and vaccines targeting CCR5. We now report a
novel deletion allele of CCR5, with an allele frequency
of 0.04, in sooty mangabey monkeys (Cercocebus
torquatus atys), a natural host of SIV (SIVsmm) [10]. The
mutant protein was not expressed at the cell surface
and accordingly did not function as a viral coreceptor.
Primary activated lymphocytes from mangabeys
heterozygous for the deletion allele expressed
significantly less CCR5 on the cell surface. Moreover,
SIV seroprevalence and viremia were comparable
among CCR5 heterozygotes and wild-type animals.
Parallel evolution of CCR5-null alleles in humans and
sooty mangabeys suggests that similar negative
selection pressures have acted against CCR5, as would
occur during epidemics of infectious agents that require
CCR5 for pathogenesis. Sooty mangabeys bred to
homozygosity for the deletion allele will be useful for
experimental studies on the context-dependent role of
CCR5 in host defense and microbial pathogenesis.
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Results and discussion
Two alleles of sooty mangabey CCR5 (smCCR5) were
cloned by PCR using genomic DNA templates from six
animals residing at the Yerkes Regional Primate Research
Center. The wild-type smCCR5 allele (Genbank accession
number AF079472) has 97.5% nucleotide sequence simi-
larity to human CCR5 (huCCR5) [11] and 99.1% similarity
to rhesus macaque CCR5 (rhCCR5) [6]. The second allele
(smCCR5∆24; Genbank accession number AF079473) con-
tains a 24 bp deletion corresponding to eight amino acids
within the predicted fourth transmembrane segment. In
addition to this deletion, the two smCCR5 alleles differed
from one another at two sites representing a silent Leu236
mutation and a Ser180→Pro amino-acid substitution in
the wild-type protein. 
To evaluate both smCCR5 alleles for their capacity to
mediate viral fusion and entry, we used a transient trans-
fection/infection assay based on flow cytometric detection
of intracellular SIV gag p27 as a marker of viral infection of
cells [12]. SIVmac239, a CCR5-utilizing virus (R5 virus),
established comparable levels of infection in COS-7 cells
cotransfected with huCD4 and either huCCR5, rhCCR5 or
wild-type smCCR5, but was unable to infect COS-7 cells
Figure 1
SIV gag p27 expression after SIVmac239 challenge of COS-7 cells
transiently transfected with CCR5 expression vectors. Infection studies
were performed using a method previously described for HIV-1
infection studies [12]. Transiently transfected COS-7 cells were
infected in triplicate with doses of 32,000 TCID50 of a stock of
SIVmac239 passaged once on CEM × 174 cells. SIV gag p27
expression detected by flow cytometry was used to identify cells that
had been infected by SIVmac239 after gating on transfected CD4+
cells. Transfection efficiency for CD4 and CCR5 constructs was
10–20% in each experiment. NS, not significant.
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transfected with huCD4 alone (Figure 1). Similar experi-
ments indicated that smCCR5 functioned as well as
huCCR5 as a viral coreceptor for HIV-1Ba-L, another R5
virus (data not shown). These experiments indicate con-
served function of the wild-type sooty mangabey homo-
logue of CCR5 as a viral receptor. In contrast, SIVmac239
did not infect COS-7 cells cotransfected with huCD4 and
smCCR5∆24 significantly more than cells transfected with
vector controls, indicating loss of smCCR5∆24 function as
a viral coreceptor.
To explain why smCCR5∆24 fails as a viral coreceptor, we
evaluated the cell-surface expression of deleted and wild-
type alleles of CCR5 in transiently transfected COS-7
cells. CCR5 amplicons were cloned into the mammalian
expression vector pcDNA3 (Invitrogen) with a signal
sequence and the FLAG epitope (DYKDDDDK in the
single-letter amino-acid code) fused to the amino terminus
[13] to allow detection of intracellular translation if the
protein failed to be expressed on the cell surface. Surface
expression and total expression were visualized by
immunofluorescence microscopy (Figure 2) and quanti-
tated by flow cytometry (Table 1) using an anti-FLAG
monoclonal antibody (M2) before and after cell fixation
and membrane permeabilization. Transfection with wild-
type CCR5 plasmids produced high levels of CCR5
expression on the surface of viable cells, whereas surface
expression of smCCR5∆24 was not detected. In contrast,
staining of fixed and permeabilized smCCR5∆24-trans-
fected cells revealed an abundance of the translated
protein inside cells. This verified that the construct was
translated but that the mutant protein failed to be trans-
ported to the cell surface. It is likely that the lack of cell-
surface expression is due to the 24 bp deletion disrupting
the fourth transmembrane segment. The mutant protein
also differs from the wild type by a proline-to-serine sub-
stitution at position 180, but this is unlikely to affect
expression because the serine codon is conserved in all
reported primate CCR5 sequences.
The expression of CCR5 on primary sooty mangabey
peripheral blood mononuclear cells (PBMCs) was evaluated
by flow cytometry using an anti-human-CCR5 antibody that
cross-reacted with smCCR5. Seven days after activation of
PBMCs, surface expression (measured by mean channel
fluorescence) was 2.4-fold higher in six smCCR5/smCCR5
mangabeys than in six smCCR5/smCCR5∆24 mangabeys
(Figure 3; p = 0.002). The decreased cell-surface expression
of CCR5 in mangabeys heterozygous for the smCCR5∆24
allele indicates that the identified deletion is not due to a
PCR artifact and that the smCCR5∆24 sequence does not
represent a pseudogene. In addition, the expression of
smCCR5 on PBMCs was similar in SIVsmm-infected and
uninfected sooty mangabeys. An analogous decrease of
CCR5 expression has been observed in humans heterozy-
gous for the 32 bp deletion allele of CCR5 [14] and attrib-
uted to multimerization between the wild-type and the
truncated gene products causing retention of CCR5 in the
endoplasmic reticulum [15]. 
To assess the frequency of the smCCR5∆24 allele, all sooty
mangabeys residing at the Yerkes Regional Primate
Research Center were genotyped using a PCR-based assay
and genomic DNA extracted from PBMCs. Of 259 animals
tested, 238 were homozygous wild type (smCCR5/smCCR5)
and 21 were heterozygous (smCCR5/smCCR5∆24). No
homozygous smCCR5∆24/smCCR5∆24 mangabeys were
identified. Hence, the allele frequency for smCCR5∆24 at
this particular primate center is estimated to be 0.04 (from
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Figure 2
Surface and total expression of FLAG-tagged CCR5 transfected into
COS-7 cells. Expression of FLAG-tagged smCCR5 and smCCR5∆24
was detected by staining cells with phycoerythrin (PE)-conjugated anti-
FLAG antibodies (Kodak) and visualized by immunofluorescence
microscopy at 400× using a Leitz Diaplan microscope and Rho Filter
(450–490 bandpass excitation, 525 ± 20 bandpass emission).
Surface expression was detected before permeabilization and total
expression was detected after permeabilization (Fix and Perm Kit;
Caltag) of cells transfected in parallel. Film exposure and processing
was constant for all panels.
Table 1
Quantitation of CCR5 expression in transfected cells.
Surface expression Total expression
Receptor % Positive MFI* % Positive MFI*†
huCCR5 13.3 90 15.2 417
rhCCR5 12.5 128 17.7 450
smCCR5 13.0 135 15.3 424
smCCR5∆24 – – 12.7 324
*Mean fluorescence intensity (MFI) is displayed after subtracting the
background measured in cells transfected with vector controls.
†Background was higher after fixation and permeabilization.
21/2 × 259). The sooty mangabey breeding colony at
Yerkes was founded between 1968 and 1969 by combining
27 animals from other laboratories [16]. Potential founder
effects in the Yerkes colony were evaluated by an analysis
of 34 unrelated sooty mangabeys residing in West Africa
[17]. Of these mangabeys, 17 were feral and 17 were house-
hold pets originally captured from feral groups. Of these 34
mangabeys, 31 were wild type and 3 were heterozygous for
the smCCR∆24 allele, representing an allele frequency of
0.04 in West Africa. Assuming a Hardy–Weinberg equilib-
rium, the expected prevalence of the deletion allele in the
homozygous state would be 0.0016 (q2 = 0.0016). Hence,
failure to identify a smCCR5∆24/smCCR5∆24 mangabey in
this analysis of 293 mangabeys does not provide evidence
for a lethal recessive phenotype.
Seroprevalence was comparable in heterozygous and
wild-type sooty mangabeys (10/21 = 48% versus
22/38 = 58%, respectively). The level of viremia among
seropositive mangabeys, measured using a quantitative
competitive reverse transcription PCR assay [18], was
comparable among seven wild-type animals (mean 6.1
log10 RNA copies/ml; range 5.2 to 6.7) relative to five het-
erozygous animals (mean 6.5 log10 RNA copies/ml; range
5.6 to 7.0; p is not significant). Analogous comparisons of
seroprevalent humans heterozygous for CCR5∆32 also
revealed no difference in viremia, although a small
decrease in viremia (mean ∆log10 = –0.39) was detectable
in heterozygous humans when duration of infection was
known and controlled for in analysis [19]. Although too
few heterozygous mangabeys are available to detect small
differences in viremia, this analysis demonstrates that
sooty mangabeys heterozygous for CCR5∆24 can be natu-
rally infected with SIV and that SIV infection results in
typical high level viremia [20]. 
The significance of the smCCR5 deletion allele in
SIVsmm–host interactions remains unclear. At present,
resistance to SIVsmm infection among CCR5-null sooty
mangabeys would not confer a substantial reproductive
advantage because SIVsmm-infected sooty mangabeys do
not have higher rates of mortality or morbidity [21]. It is
possible that viruses ancestral to current SIVsmm variants
were pathogenic upon introduction into mangabey popu-
lations and that polymorphisms of viral receptors which
decreased susceptibility to infection or disease were
selected. Interestingly, sooty mangabey CD4 is also poly-
morphic, with two alleles that differ by 4 amino acids
including a tyrosine-to-isoleucine substitution in the com-
plementarity determining region 2 (CDR2) [22] that is
involved in env–CD4 interactions. Although mutant
alleles of CD4 and CCR5 in sooty mangabeys are no
longer essential for host tolerance of current SIVsmm
infection, these host polymorphisms may persist as vesti-
gial remnants of prior selection against wild-type alleles. 
The parallel evolution of CCR5 null alleles, one in the
natural host of SIVsmm and the other conferring high
resistance to HIV-1 in humans, suggests that ancient epi-
demics of ancestral viruses may have been important in
shaping primate genomes. The high incidence of endoge-
nous retroviruses (1%) and RNA-derived DNA (5%) in
the human genome suggests a role for retroviruses in
shaping human evolution (reviewed by Lower et al. [23]).
Alternatively, epidemics of non-viral pathogens may
account for selection against CCR5. Indeed, the plagues of
‘Black Death’ that claimed the lives of 25–35% of Euro-
peans from 1346 to 1352 coincide with selection for
CCR5∆32 in Caucasians estimated to have occurred about
700 years ago by analysis of linked microsatellite loci [24].
It is unlikely that the CCR5 deletions in sooty mangabeys
and humans occurred in the same geographic region given
that there is no fossil evidence for Cercocebus monkeys on
the European continent [25] and CCR5∆32 is extremely
rare in Africans.
The selective advantages of CCR5 wild-type function may
not be important in all ecological contexts. Humans with
CCR5-null phenotype are apparently healthy; however,
reported cases have resided in settings where some infec-
tious pathogens are rare and infection with common
pathogens is less likely to be fatal because medical therapy
is accessible and effective. Chemokines that bind CCR5 as
a receptor are known to be involved in inflammatory
responses to infection with Mycobacterium tuberculosis [26],
Coxsackievirus [27] and Yersinia enterocolitica [28] and are
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Figure 3
CCR5 expression on sooty mangabey blood lymphocytes. PBMCs
were activated with anti-simian-CD3 antibodies (BioSource), and
recombinant human interleukin-2 (100 U/ml; Chiron) was added to the
culture 2 days after activation. Lymphocytes were identified using flow
cytometry by forward and side-scatter characteristics and were
assayed by staining with PE-conjugated anti-CCR5 antibody (3A9) for
expression of CCR5 on day 7 after activation. Mean fluorescence
intensity was measured after subtracting isotype-matched negative
control values. Solid circles represent SIV-seropositive mangabeys and
open circles represent SIV-seronegative mangabeys.
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likely to be involved in Th1 host responses to other
pathogens [29]. Although CCR5 function is neutral in
some circumstances, the gene may confer a survival advan-
tage (or disadvantage) in other settings.
The natural role of CCR5 needs to be understood for the
evaluation of the safety of therapy and vaccines designed to
interfere with HIV-1 and HIV-2 interactions with CCR5.
The consequences of CCR5 inhibition are not known in all
settings, particularly in underdeveloped areas where subtle
or specific immunodeficiencies may have more marked
consequences. Safety data collected in wealthy countries,
where the CCR5-null phenotype is not lethal, may not be
relevant to developing countries where vaccines and thera-
pies are most needed. Sooty mangabeys with the CCR5-
null phenotype, once bred to homozygosity, may prove to
be important for the identification of circumstances in
which CCR5 confers a selective advantage or disadvantage,
which becomes evident after challenge with epidemiologic
agents including SIV and Yersinia species.
Supplementary material
Additional methodological details and figures showing sequence represen-
tations and PCR genotype analysis are available as Supplementary material
published with this article on the internet.
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Materials and methods
Cloning and sequencing of mangabey CCR5
Full-length sooty mangabey CCR5 was amplified by PCR using primers
that bind outside the open reading frame (ORF). Primers were (forward)
5′-TCGAAAGCTTCCCCGGGTGGAACAAGATG-3′ and (reverse) 5′-
CTGAGGATCCGCCATGTGGCACAACTCT-3′, corresponding to the
published human CCR5 sequence. The forward primer overlaps the
start ATG and the reverse primer lies downstream of the presumed stop
codon. The PCR reactions contained rTth DNA polymerase XL (2.5
units) in XL Buffer II (Perkin Elmer), Mn(OAc)2 (2.25 mM), primers
(0.4 mM each), dNTPs (0.2 mM) each in a 50 µl reaction volume. Ther-
mocycling conditions were as follows: an initial 3 min denaturation step
at 94°C followed by 45 cycles of 10 sec at 93°C, 15 sec at 45°C and
30 sec at 72°C, and a final extension step of 10 min at 72°C. Genomic
DNA from sooty mangabey PBMCs was extracted from buffy coats
using silica columns (Qiagen) and 0.1–0.5 µg was used as template
DNA for all amplification reactions. Resulting products were TA-cloned
into the pGEM-T vector (Promega), and the amino and carboxyl termini
of multiple clones from several animals (including possible heterozy-
gotes) were sequenced by d-rhodamine-labeled terminators and SP6
and T7 sequencing primers. The first and last 18 bp of the cloned ORFs
were identical in sequences from all six mangabeys, including heterozy-
gous smCCR5/smCCR5∆24 mangabeys, and this sequence was used
for designing species-specific primers.
For full-length sequencing and functional analysis, CCR5 amplicons
were cloned into the mammalian expression vector pcDNA3 (Invitro-
gen) with the signal sequence FLAG epitope (DYKDDDDK) fused to
the amino terminus. CCR5 sequences were PCR-amplified using
primers (forward) 5′-TCGACTCGAGGATTATCAAGTGTCAAGT-3′
and (reverse) 5′-TCGATCTAGATTAGCTGGAGTGAAAACT-3′, where
the forward primer overlaps the first 18 bp of the ORF while deleting
the start methionine codon, and the reverse primer overlaps the last
16 bp of the ORF (XbaI and XhoI sites are underlined). PCR and
cycling conditions were as described above except that a lower dNTP
concentration (0.1 mM) and a lower cycle number (35) were used to
increase the fidelity of the PCR. 
Cloning of FLAG-tagged sooty mangabey CCR5 sequences was
achieved by trimolecular ligation of gel-purified PCR products digested
with XhoI and XbaI, a FLAG sequence released from pBlueScript SK
Prol/Flag with HindIII and XhoI, and pcDNA3 digested with HindIII and
XbaI. Colonies were screened by colony PCR for proper insert length
and orientation. Rhesus macaque CCR5 was cloned in an analogous
manner, and the sequence obtained agreed with the published
sequence. All constructs used were sequenced on both strands to
confirm inserts and allelic differences. Allele sequences were con-
firmed by comparison of at least three sequences of each allele that
were independently amplified and cloned from at least three sooty
mangabeys. FLAG-tagged huCCR5 was previously described.
CCR5 genotyping of sooty mangabeys
A PCR-based genotyping assay was adapted from a previously
reported method for identification of CCR5∆32 alleles in human
genomic DNA. PCR was performed on genomic DNA extracts pre-
pared as described above. Genomic DNA (0.3–0.6 µg) was amplified
using 5′-TGTTTGCTTTAAAAGCCAGGACAGTCACCTTTGG-3′ and
5′-GAGTGGGTCACCGGIACACTTGAGTCCAGGTCA-3′ as forward
and reverse primers, respectively. PCR mixtures contained 5% DMSO,
MgCl2 (1.5 mM), primers (0.5 µM each), dNTPs (0.2 µM each) and Taq
polymerase (0.6 U) in Perkin Elmer Buffer II (Perkin Elmer) in a reaction
volume of 12 µl. Plasmid DNAs (35 pg) were used as controls in each
PCR to simulate amplification of homozygotes (single plasmids) and
heterozygotes (both plasmids). Cycling conditions were as follows: one
denaturation step at 94°C, followed by 35 cycles of 1 min at 93°C,
1 min at 60°C, 1 min at 72°C, followed by a final extention step of
10 min at 72°C. The 689 bp PCR product (5 µl) was digested with 5U
EcoRI for 1 h at 37°C, and the cleaved products electrophoresed in a
3% NuSieve agarose gel (FMC), stained with ethidium bromide, and
visualized with ultraviolet light. 
Transient expression studies and infection assay
COS-7 cells were maintained in Iscoves medium containing 10% FBS
with antibiotics. Cells were plated overnight in 6-well plates at 3 × 105
cells per well in 2 ml DMEM with 10% FBS with antibiotics. After 24 h,
monolayers were cotransfected with pcDNA3 vector alone, human
CD4 0.5 µg alone, or human CD4 0.5 µg with 1 µg of either huCCR5,
rhCCR5, smCCR5, smCCR5∆24, or pcDNA3 vector using the Lipo-
fectamine method (Life Technologies). After 24 h, cells were harvested
and receptor expression was measured by multiparameter flow cytome-
try. CD4 expression was detected using a FITC-conjugated anti-CD4
monoclonal antibody (Becton Dickinson), and chemokine receptor
expression by staining with phycoerythrin (PE)-conjugated M2 anti-
FLAG antibody (Kodak). Surface expression was characterized by
staining live cells that excluded propidium iodide. Intracellular expres-
sion was detected by using the Fix and Perm Kit (Caltag) on replicate
transfected wells. Surface and intracellular expression staining was
done in parallel and in triplicate. Vector-transfected monolayers were
stained and used as negative controls for flow cytometry analysis.
A low passage stock of SIVmac239 was amplified on CEM × 174 cells.
For infection assays, COS-7 cells were transfected as described
above and then infected with 32,000 TCID50 (~250 ng p27) of
SIVmac239 on the following day. Inoculum was replaced the next day.
After 72 h, SIV-infected monolayers were harvested, fixed and perme-
abilized, and stained for CD4 and SIV gag p27 core antigen with an
anti-p27 mouse monoclonal antibody (Fitzgerald Industries), a FITC-
conjugated goat anti-mouse antibody (Becton Dickinson), and finally
with a PE-conjugated anti-CD4 antibody. Cells positive for p27 were
assayed after gating on transfected (CD4+) cells. Infections were per-
formed in triplicate.
Flow cytometry analysis of activated peripheral blood
lymphocytes
PE-conjugated 3A9 antibody (LeukoSite) was found to cross-react with
sooty mangabey CCR5 and was used for in vivo expression studies.
PBMC were cultured from six smCCR5/smCCR5∆24 heterozygous
animals and from six smCCR5/smCCR5 homozygous animals as deter-
mined by PCR genotyping. Within each genotype, three animals were
HIV-2 seronegative and three were seropositive. PBMCs were acti-
vated with anti-simian-CD3 antibodies (BioSource), and recombinant
human interleukin-2 (100 U/ml) (Chiron) was added to the culture 2
days after activation. Lymphocytes were identified using multiparameter
flow cytometry by forward and side-scatter characteristics and were
assayed for expression of CCR5 by staining with 3A9 PE-conjugated
antibody on day 7 after activation. An irrelevant PE-conjugated IgG2α
Supplementary material
antibody was used to detect nonspecific binding and did not stain sig-
nificantly. Propidium iodide was used to exclude dead cells.
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Schematic representation of primate CCR5 proteins and gene
sequences. (a) Wild-type simian CCR5 proteins relative to the human
protein. Open circles represent differences relative to the human
protein that are common to both rhesus macaques and sooty
mangabeys. Filled circles represent differences between the sooty
mangabey and both human and rhesus CCR5. The open square
represents a difference between the rhesus macaque CCR5 and both
mangabey and human CCR5. Amino acid changes are denoted with
human CCR5 as the reference protein. (b) Schematic of smCCR5∆24
protein indicating the predicted position of the 24 bp deletion if it were
expressed at the plasma membrane. The filled squares represents
codon differences between the two sooty mangabey alleles.
(c) Nucleotide alignment of the wild-type and deletion alleles of human
and sooty mangabey CCR5. Solid lines above the alignment indicate
the seven predicted transmembrane (TM) domains of the
corresponding protein.
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Figure S2
PCR-based genotyping assay of smCCR5 genotype. A 689 bp or
665 bp fragment of smCCR5 was PCR-amplified from genomic DNA
using smCCR5-specific primers and digested with EcoRI, which cuts
once within either allele. A common downstream (relative to the EcoRI
site) band of 305 bp is released. The wild-type smCCR5 allele
releases a 384 bp upstream fragment while smCCR5∆24 (∆24)
releases a 360 bp fragment. Homozygotes of either allele produce only
two bands, the common 305 bp band and either the 384 bp (wild-
type) or 360 bp (smCCR5∆24) band. A heterozygote animal produces
all three bands. Plasmid controls were amplified with the genomic DNA
being tested. No PCR products were evident in the negative control
reactions run with every assay (data not shown). Sizes of fragments (in
bp) are indicated to the right of the gel.
Plasmid
controls
C
C
R
5
ha
pl
ot
yp
es
384
360
305
Sooty 
mangabeys
Current Biology   
+
∆24
+
+
+
+
+
+
+
+
+
+
+
∆24
+
∆24
∆24
∆24
